Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3422]

Mesothelin-targeted CAR T-cell therapy safe, shows early promise in patients...

Dr Prasad Adusumilli - Memorial Sloan Kettering Cancer Center, New York, USA

Mesothelin-targeted CAR T-cell therapy safe, shows early promise in patients with advanced solid tumours ( Dr Prasad Adusumilli - Memorial Sloan Kettering Cancer Center, New York, USA )

HER2-targeted CAR T-cell therapy safe and showing promising antitumour activity...

Prof Shoba Navai - Baylor College of Medicine, Houston, USA

HER2-targeted CAR T-cell therapy safe and showing promising antitumour activity in patients with advanced sarcoma ( Prof Shoba Navai - Baylor College of Medicine, Houston, USA )

Cancer preventive vaccine showed promising results in preclinical model of...

Prof Steven Lipkin - Weill Cornell Medical College, New York, USA

Cancer preventive vaccine showed promising results in preclinical model of Lynch syndrome ( Prof Steven Lipkin - Weill Cornell Medical College, New York, USA )

Umbralisib shows early promise for patients with marginal zone lymphoma

Prof Nathan Fowler - MD Anderson Cancer Center, Houston, USA

Umbralisib shows early promise for patients with marginal zone lymphoma ( Prof Nathan Fowler - MD Anderson Cancer Center, Houston, USA )

Gilteritinib improved survival for patients with acute myeloid leukaemia

Prof Alexander Perl - University of Pennsylvania, Philadelphia, USA

Gilteritinib improved survival for patients with acute myeloid leukaemia ( Prof Alexander Perl - University of Pennsylvania, Philadelphia, USA )

GU Debates 2019: Changing treatment paradigms for hormone-naïve and castration...

Dr Eleni Efstathiou, Prof Peter Goebell, Prof Joaquim Bellmunt, Prof Thomas...

GU Debates 2019: Changing treatment paradigms for hormone-naïve and castration-resistant prostate cancer (1/2) ( Dr Eleni Efstathiou, Prof Peter Goebell, Prof Joaquim Bellmunt, Prof Thomas Steuber )

GU Debates 2019: Practice-changing developments in urothelial cancer (2/2)

GU Debates 2019: Practice-changing developments in urothelial cancer (2/2) ( )

Latest updates in melanoma research

Dr Alexander van Akkooi - The Netherlands Cancer Institute, Amsterdam...

Latest updates in melanoma research ( Dr Alexander van Akkooi - The Netherlands Cancer Institute, Amsterdam, Netherlands )

ASCO GU 2019: Treatment and management of hormone-sensitive metastatic prostate...

Prof Karim Fizazi, Dr Eleni Efstathiou

ASCO GU 2019: Treatment and management of hormone-sensitive metastatic prostate cancer ( Prof Karim Fizazi, Dr Eleni Efstathiou )

Latest from CheckMate 650: Nivolumab plus ipilimumab for the treatment of...

Dr Sumit Subudhi - MD Anderson Cancer Center, Houston, USA

Latest from CheckMate 650: Nivolumab plus ipilimumab for the treatment of metastatic castration-resistant prostate cancer ( Dr Sumit Subudhi - MD Anderson Cancer Center, Houston, USA )

ASCO GU 2019: Updates on treatment and management of bladder cancer

Professor Matthew Galsky, Professor Ananya Choudhury, Professor Joaquim...

ASCO GU 2019: Updates on treatment and management of bladder cancer ( Professor Matthew Galsky, Professor Ananya Choudhury, Professor Joaquim Bellmunt, Dr Andrea Necchi )

ASCO GU 2019: Updates on non-metastatic castration-resistant prostate cancer

Prof Karim Fizazi, Dr Eleni Efstathiou, Prof Boris Hadaschik, Prof Nicholas...

ASCO GU 2019: Updates on non-metastatic castration-resistant prostate cancer ( Prof Karim Fizazi, Dr Eleni Efstathiou, Prof Boris Hadaschik, Prof Nicholas Mottet )

More from ecancer